Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Heidi D Klepin Boris Pasche Timothy S Pardee Lance Miller Ralph B. D'Agostino Jr |
| Publication date | May 8, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |